{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:04:31Z","timestamp":1779887071976,"version":"3.53.1"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The ratio of percentage of prostate cancer (PCa) biopsy-positive cores (BPC) to prostate volume as the index density factor (Id-BPC) was used to predict the risk of high tumour grades in the surgical specimens of European Association of Urology (EAU) intermediate-risk patients treated with robotic surgery. Methods: From January 2013 to December 2021, we evaluated 651 patients without any prior treatment for PCa. In the surgical specimen, tumour grades were classified as indolent (International Society of Urological Pathologists Classification (ISUP) 1), significant (ISUP 2\/3), and lethal (ISUP 4\/5). Associations with the risk of significant and lethal cancers were assessed by the multinomial logistic regression model. Results: Tumour grade was clinically significant (ISUP 2\/3) in 522 (80.2%) cases and lethal (ISUP 4\/5) in 99 (15.2%), while the results were not significant (ISUP 1) in 30 (4.6%) subjects. The association of Id-BPC was always stronger than BPC for ISUP 1 vs. 4\/5 (OR = 0.284; 95% CI: 0.128\u20130.632; p = 0.002), ISUP 2\/3 vs. 4\/5 (OR = 0.744; 95% CI: 0.586\u20130.946; p = 0.016), and ISUP 1 vs. 2\/3 (OR = 0.382; 95% CI: 0.176\u20130.828; p = 0.015), and this trend held after adjusting for clinical factors. Conclusions: Accordingly, Id-BPC was positively associated with lethal disease, as, when it increased or decreased, it was more or less likely, respectively, to find ISUP 4\/5 in the surgical specimens of the operated subjects, who could have been stratified according to Id-BPC risk levels.<\/jats:p>","DOI":"10.3390\/cancers18030410","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:56:12Z","timestamp":1769615772000},"page":"410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Index Density, the Ratio of Percentage of Biopsy-Positive Cores to Prostate Volume, and Predicted Lethal Disease in the EAU Intermediate Prognostic Risk Class: Analysis and Implications in 651 Consecutive Patients Treated with Robot-Assisted Radical Prostatectomy at a Tertiary Referral Centre"],"prefix":"10.3390","volume":"18","author":[{"given":"Antonio Benito","family":"Porcaro","sequence":"first","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Cerruto","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-4601","authenticated-orcid":false,"given":"Riccardo Giuseppe","family":"Bertolo","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Artoni","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Baielli","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Montanaro","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-3206","authenticated-orcid":false,"given":"Alessandro","family":"Veccia","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Rizzetto","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Brunelli","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Siracusano","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref_1","unstructured":"Cornford, P., Tilki, D., van den Bergh, R.C., Eberli, D., De Meerleer, G., De Santis, M., Gillessen, S., Henry, A.M., van Leenders, G.J.L.H., and Oldenburg, J. (2025, November 01). Eau-Eanm-Estro-Esur-Isup-Siog Guidelines on Prostate Cancer\u20142025 Update. Available online: https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"key":"ref_2","first-page":"141","article-title":"NCCN Guidelines\u00ae Insights: Prostate Cancer, Version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European Study of Prostate Cancer Screening\u201423-Year Follow-up","volume":"293","author":"Roobol","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaoncol.2021.5160","article-title":"Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics with Treatment-Related Regret Among Men with Localized Prostate Cancer","volume":"8","author":"Wallis","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.euo.2023.11.018","article-title":"A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer","volume":"7","author":"Slevin","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/bju.15220","article-title":"Indications for and complications of pelvic lymph node dissection in prostate cancer: Accuracy of available nomograms for the prediction of lymph node invasion","volume":"127","author":"Oderda","year":"2021","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Parry, M.G., Cowling, T.E., Sujenthiran, A., Nossiter, J., Berry, B., Cathcart, P., Aggarwal, A., Payne, H., van der Meulen, J., and Clarke, N.W. (2020). Risk stratification for prostate cancer management: Value of the Cambridge Prognostic Group classification for assessing treatment allocation. BMC Med., 18.","DOI":"10.1186\/s12916-020-01588-9"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review","volume":"75","author":"Broeck","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","article-title":"External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort","volume":"75","author":"Tilki","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score","volume":"69","author":"Epstein","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.eururo.2013.03.033","article-title":"A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy","volume":"64","author":"Zumsteg","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/cncr.32778","article-title":"Validation of a subclassification for high-risk prostate cancer in a pro-spective cohort","volume":"126","author":"Butler","year":"2020","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamaoncol.2017.1879","article-title":"Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group","volume":"4","author":"Patel","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/iju.12748","article-title":"Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer","volume":"222","author":"Moschini","year":"2015","journal-title":"Int. J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41391-024-00852-w","article-title":"Risk calculators for the detection of prostate cancer: A systematic review","volume":"27","author":"Denijs","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41391-024-00859-3","article-title":"Integrating risk calculators into routine clinical workflow for the detection of prostate cancer: Next steps to achieve widespread adoption","volume":"27","author":"Anger","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Telecan, T., Chiorean, A., Sipos-Lascu, R., Caraiani, C., Boca, B., Hendea, R.M., Buliga, T., Andras, I., Crisan, N., and Lupsor-Platon, M. (2025). ISUP Grade Prediction of Prostate Nodules on T2WI Acquisitions Using Clinical Features, Textural Parameters and Machine Learning-Based Algorithms. Cancers, 17.","DOI":"10.3390\/cancers17122035"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cerruto, M.A., Porcaro, A.B., Bianchi, A., Tafuri, A., Panunzio, A., Orlando, R., Montanaro, F., Baielli, A., Artoni, F., and Franceschini, A. (2025). Index Cancer Density Is a Stronger Predictor of Pelvic Lymph Node Invasion than Percentage of Biopsy-Positive Cores in EAU High-Risk Prostate Cancer: Clinical Impact in 254 Patients Treated and Staged with Robot-Assisted Radical Prostatectomy. Cancers, 17.","DOI":"10.3390\/cancers17203385"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MOU.0000000000000671","article-title":"Active surveillance for intermediate-risk prostate cancer: Yes, but for whom?","volume":"29","author":"Overland","year":"2019","journal-title":"Curr. Opin. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bju.14935","article-title":"Active surveillance in intermediate-risk prostate cancer","volume":"125","author":"Klotz","year":"2020","journal-title":"BJU Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.urology.2022.09.007","article-title":"MRI vs Transrectal Ultrasound to Estimate Prostate Volume and PSAD: Impact on Prostate Cancer Detection","volume":"171","author":"Choe","year":"2023","journal-title":"Urology"},{"key":"ref_25","first-page":"1","article-title":"The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-na\u00efve Men","volume":"60","author":"Ye","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.clgc.2025.102300","article-title":"Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy Patients","volume":"23","author":"Longoni","year":"2025","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tolksdorf, J., Kattan, M.W., Boorjian, S.A., Freedland, S.J., Saba, K., Poyet, C., Guerrios, L., De Hoedt, A., Liss, M.A., and Leach, R.J. (2019). Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools. BMC Med. Res. Methodol., 19.","DOI":"10.1186\/s12874-019-0839-0"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12253-019-00632-1","article-title":"Prognostic Differences in ISUP Grade Group 4: A Systematic Review and Meta-Analysis","volume":"26","author":"Lu","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s11255-025-04510-5","article-title":"Patient satisfaction and decision regret in patients undergoing radical prostatectomy: A multicenter analysis","volume":"57","author":"Guercio","year":"2025","journal-title":"Int. Urol. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2020.12.015","article-title":"Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis","volume":"149","author":"Lindsay","year":"2021","journal-title":"Urology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:03:12Z","timestamp":1769616192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030410"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030410","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}